Patents by Inventor Giorgio Cavallini

Giorgio Cavallini has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Combined use of L-carnitine, acetyle L-carnitine and propionyl L-carnitine for the treatment of oligoasthenoteratospermia
    Patent number: 8415392
    Abstract: L-carnitine, acetyl L-carnitine and propionyl L-carnitine inner salts, or their pharmaceutically acceptable salts, are used in combination to treat oligoasthenoteratosperia including oligospermia, asthenospermia, and teratospermia.
    Type: Grant
    Filed: September 9, 2008
    Date of Patent: April 9, 2013
    Assignee: Sigma-Tau Industrie Farmaceutiche Riunite, S.p.A.
    Inventors: Giorgio Cavallini, Giulio Biagiotti, Aleardo Koverech, Francesca Sardelli
  • Use of acetyl L-carnitine in combination with propionyl L-carnitine and Sildenafil for the treatment of erectile dysfunction
    Patent number: 8003652
    Abstract: The use of acetyl L-carnitine in combination with propionyl L-carnitine and sildenafil is described for the preparation of a medicament and/or dietetic product for the treatment of erectile dysfunction secondary to all those conditions in which there is distress or iatrogenic damage of the lesser pelvis within which the neurovascular bundles of the penis run.
    Type: Grant
    Filed: October 19, 2005
    Date of Patent: August 23, 2011
    Assignee: Sigma-Tau Industrie Farmaceutiche Riunite, S.p.A.
    Inventors: Aleardo Koverech, Giorgio Cavallini
  • Use of carnitines for the prevention and/or treatment of disorders caused by the andropause
    Patent number: 7956091
    Abstract: The use of propionyl L-carnitine in combination with acetyl L-carnitine, or one of their pharmaceutically acceptable salts, is disclosed for the preparation of a medicament, or of a nutritional supplement, for the prevention and/or treatment of the disorders of the male andropause caused by ageing or by chemical or surgical castration.
    Type: Grant
    Filed: November 20, 2003
    Date of Patent: June 7, 2011
    Assignee: Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.
    Inventors: Aleardo Koverech, Giorgio Cavallini, Giulio Biagiotti
  • Carnitines for treating or preventing disorders caused by andropause
    Patent number: 7776913
    Abstract: L-carnitine, propionyl L-carnitine and/or acetyl L-carnitine are used to prevent or treat disorders of male andropause caused by ageing or by chemical or surgical castration.
    Type: Grant
    Filed: March 14, 2008
    Date of Patent: August 17, 2010
    Assignee: Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.
    Inventors: Aleardo Koverech, Giulio Biagiotti, Giorgio Cavallini
  • Combined use of L-carnitine, acetyle L-carnitine and propionyl L-carnitine for the treatment of oligoasthenoteratospermia
    Publication number: 20090012169
    Abstract: L-carnitine, acetyl L-carnitine and propionyl L-carnitine inner salts, or their pharmaceutically acceptable salts, are used in combination to treat oligoasthenoteratosperia including oligospermia, asthenospermia, and teratospermia.
    Type: Application
    Filed: September 9, 2008
    Publication date: January 8, 2009
    Applicant: SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A.
    Inventors: Giorgio Cavallini, Giulio Biagiotti, Aleardo Koverech, Francesca Sardelli
  • Use of carnitines for the prevention and/or treatment of disorders caused by the andropause
    Publication number: 20080287539
    Abstract: L-carnitine, propionyl L-carnitine and/or acetyl L-carnitine are used to prevent or treat disorders of male andropause caused by ageing or by chemical or surgical castration.
    Type: Application
    Filed: March 14, 2008
    Publication date: November 20, 2008
    Applicant: Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.,
    Inventors: Aleardo Koverech, Giulio Biagiotti, Giorgio Cavallini
  • Use of Acetyl L-Carnitine In Combination With Propionyl L-Carnitine and Sildenafil for the Treatment of Erectile Dysfunction
    Publication number: 20080090906
    Abstract: The use of acetyl L-carnitine in combination with propionyl L-carnitine and sildenafil is described for the preparation of a medicament and/or dietetic product for the treatment of erectile dysfunction secondary to all those conditions in which there is distress or iatrogenic damage of the lesser pelvis within which the neurovascular bundles of the penis run.
    Type: Application
    Filed: October 19, 2005
    Publication date: April 17, 2008
    Applicant: SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A.
    Inventors: Aleardo Koverech, Giorgio Cavallini
  • Use of carnitines for the prevention and/or treatment of disorders caused by the andropause
    Publication number: 20060135606
    Abstract: The use of propionyl L-carnitine in combination with acetyl L-carnitine, or one of their pharmaceutically acceptable salts, is disclosed for the preparation of a medicament, or of a nutritional supplement, for the prevention and/or treatment of the disorders of the male andropause caused by ageing or by chemical or surgical castration.
    Type: Application
    Filed: November 20, 2003
    Publication date: June 22, 2006
    Inventors: Aleardo Koverech, Giulio Biagotti, Giorgio Cavallini
  • Use of propionyl-carnitine or one of its pharmacologically acceptable salts for the preparation of a medicine for the treatment of la peyronie's disease
    Publication number: 20050038044
    Abstract: The invention described herein relates to the use of propionyl L-carnitine or one of its pharmaceutically acceptable salts for the preparation of a medicine useful for the treatment of La Peyronie's disease in its various stages, particularly at the advanced stage and in forms resistant to conventional therapies. The medicine is suitable for oral, intramuscular, intravenous, and intraplaque administration. The invention described herein also relates to a combination of an active ingredient in the treatment of La Peyronie's disease, particularly verapamil, and propionyl L-carnitine or one of its pharmaceutically acceptable salts. Propionyl L-carnitine has proved to be more effective than the known active ingredients, also in intractable forms, and presents a lower incidence of side effects.
    Type: Application
    Filed: November 26, 2002
    Publication date: February 17, 2005
    Inventors: Aleardo Koverech, Giorgio Cavallini, Giulio Biagiotti
  • Use of alfuzosin or terazosin in the treatment of premature ejaculation
    Patent number: 5707999
    Abstract: The method of use of the .alpha.-1 blockers, alfuzosine and terazosine, in the treatment of premature ejaculation is disclosed.
    Type: Grant
    Filed: April 16, 1996
    Date of Patent: January 13, 1998
    Assignee: Synthelabo
    Inventor: Giorgio Cavallini
  • Use of minoxidil for treating erectile impotence
    Patent number: 5336678
    Abstract: A method of treatment of human erectile impotency by topical administration to the penis of a topical composition containing 0.1 to 10% minoxidil.
    Type: Grant
    Filed: October 16, 1992
    Date of Patent: August 9, 1994
    Inventor: Giorgio Cavallini